Root Financial Partners LLC lowered its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,592 shares of the company’s stock after selling 748 shares during the period. Root Financial Partners LLC’s holdings in Procter & Gamble were worth $435,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in PG. AMF Tjanstepension AB boosted its position in shares of Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the period. Creative Planning grew its holdings in Procter & Gamble by 3.5% during the 3rd quarter. Creative Planning now owns 1,393,443 shares of the company’s stock valued at $241,344,000 after buying an additional 47,551 shares in the last quarter. Swedbank AB raised its position in shares of Procter & Gamble by 3.9% during the third quarter. Swedbank AB now owns 1,503,647 shares of the company’s stock valued at $260,432,000 after buying an additional 56,583 shares during the last quarter. Indiana Trust & Investment Management Co boosted its position in shares of Procter & Gamble by 9.8% during the third quarter. Indiana Trust & Investment Management Co now owns 13,227 shares of the company’s stock worth $2,291,000 after acquiring an additional 1,182 shares during the last quarter. Finally, Amplius Wealth Advisors LLC boosted its position in shares of Procter & Gamble by 2.5% during the third quarter. Amplius Wealth Advisors LLC now owns 5,986 shares of the company’s stock worth $1,037,000 after acquiring an additional 144 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the topic of several research analyst reports. UBS Group decreased their price target on shares of Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Morgan Stanley increased their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, Stifel Nicolaus boosted their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $180.53.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $171.15 on Friday. The company has a market capitalization of $401.33 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 3.79 and a beta of 0.45. The Procter & Gamble Company has a 52 week low of $153.52 and a 52 week high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The stock’s fifty day moving average is $166.83 and its two-hundred day moving average is $169.44.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. The company had revenue of $21.88 billion during the quarter, compared to analysts’ expectations of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.84 EPS. As a group, analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Insiders Place Their Bets
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 151,097 shares of company stock worth $25,635,076. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- 3 Warren Buffett Stocks to Buy Now
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Retail Stocks Investing, Explained
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Using the MarketBeat Dividend Tax Calculator
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.